Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
Clinical trial NCT00786812 · COMPLETED
Trial details
- NCT number
- NCT00786812
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2012-01-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.